Nyastrol Syrup contains Nystatin 100,000 IU, a potent antifungal agent indicated for the treatment of oral and gastrointestinal fungal infections, including candidiasis. It helps in reducing fungal colonization, relieving discomfort, and restoring healthy mucosal balance.
Nystatin works by binding to ergosterol in the fungal cell membrane, causing increased permeability and cell death. Its oral syrup formulation ensures easy administration, especially for pediatric and geriatric patients.
For distributors and healthcare suppliers, Nyastrol Syrup is a high-demand antifungal therapy product, frequently used in hospitals, clinics, and community healthcare settings. Oral fungal infections remain common, ensuring consistent demand throughout the year.
Adding Nyastrol Syrup to your antifungal therapy segment creates strong opportunities in pharmacies, hospitals, pediatric clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, patient-friendly syrup formulation, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.